CNH Partners »

Karuna Therapeutics Ord shares owned by CNH Partners

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by CNH Partners from 13F filings

Historical chart of CNH Partners investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by CNH Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by CNH Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $47M 147k 316.51

More positions owned by CNH Partners

Karuna Therapeutics Ord
Splunk Note 1.125% 6/1 (Principal)
ImmunoGen
Albertsons Cos Common Stock (ACI)
Cerevel Therapeutics Hldng I (CERE)
United States Steel Corporation (X)
Wayfair Note 3.250% 9/1 (Principal)
PNM Resources (PNM)
Etsy Note 0.250% 6/1 (Principal)
Amedisys (AMED)
Array Technologies Note 1.000%12/0 (Principal)
Gores Holdings Ix Class A Com (GHIX)
Hess (HES)
Lci Inds Note 1.125% 5/1 (Principal)
Pioneer Natural Resources (PXD)

View all positions for CNH Partners

Top funds holding Karuna Therapeutics Ord

Vanguard Group
T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Fiera Capital Corporation
Charles Schwab Investment Management
Alpine Associates Management
Avidity Partners Management

View all funds holding Karuna Therapeutics Ord